Skip to Main Content (Press Enter)
×
Home
Persone
Strutture
Competenze
Pubblicazioni
Professioni
Corsi
Insegnamenti
Terza Missione
IT
EN
☰
Competenze & Professionalità
|
Competenze & Professionalità
unibs.it
IT
EN
×
Home
Persone
Strutture
Competenze
Pubblicazioni
Professioni
Corsi
Insegnamenti
Terza Missione
☰
Pubblicazioni
THE LANCET DIABETES & ENDOCRINOLOGY
Rivista
Codice:
E226590
ISSN:
2213-8587
Dati Generali
Dati Generali
Pubblicazioni (8)
2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial
Articolo
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
Articolo
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment
Articolo
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Articolo
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants
Articolo
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
Articolo
Growth hormone replacement therapy and fracture risk
Articolo
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
Articolo
No Results Found
